Paper32138282
Methionine Restriction and Cancer Biology.
Wanders D and 2 others. Nutrients, 2020. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Methionine Restriction and Cancer Biology. Papers, record 32138282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32138282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methionine | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| YFEL141014 | Flight Attendant Medical Research Institute | PubMed |
Source PubMed
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14585259 | Methionine dependency and cancer treatment. | Cancer Treat Rev | 2003 | https://conductscience.org/library/papers/14585259 | PubMed |
| 2 | 24373243 | The impact of dietary methionine restriction on biomarkers of metabolic health. | Prog Mol Biol Transl Sci | 2014 | https://conductscience.org/library/papers/24373243 | PubMed |
| 3 | 14627790 | Gene silencing in cancer in association with promoter hypermethylation. | N Engl J Med | 2003 | https://conductscience.org/library/papers/14627790 | PubMed |
| 4 | 12948860 | Methionine restriction selectively targets thymidylate synthase in prostate cancer cells. | Biochem Pharmacol | 2003 | https://conductscience.org/library/papers/12948860 | PubMed |
| 5 | 10228944 | Effects of epidermal growth factor on MDA-MB-468 breast cancer cells: alterations in polyamine biosynthesis and the expression of p21/CIP1/WAF1. | J Cell Physiol | 1999 | https://conductscience.org/library/papers/10228944 | PubMed |
| 6 | 23755744 | Treatment effects in prostate cancer following traditional and emerging therapies. | Int J Immunopathol Pharmacol | 2013 | https://conductscience.org/library/papers/23755744 | PubMed |
| 7 | 20871132 | Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase. | J Lipid Res | 2011 | https://conductscience.org/library/papers/20871132 | PubMed |
| 8 | 23481261 | Obesity and colorectal cancer. | Gut | 2013 | https://conductscience.org/library/papers/23481261 | PubMed |
| 9 | 23771789 | Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention. | Amino Acids | 2014 | https://conductscience.org/library/papers/23771789 | PubMed |
| 10 | 28929442 | The role of methionine on metabolism, oxidative stress, and diseases. | Amino Acids | 2017 | https://conductscience.org/library/papers/28929442 | PubMed |
| 11 | 22437869 | Combining immunotherapy and targeted therapies in cancer treatment. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22437869 | PubMed |
| 12 | 20044642 | Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma. | Anticancer Res | 2009 | https://conductscience.org/library/papers/20044642 | PubMed |
| 13 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 14 | 23236485 | Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. | PLoS One | 2012 | https://conductscience.org/library/papers/23236485 | PubMed |
| 15 | 25220842 | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25220842 | PubMed |
| 16 | 25765145 | Dietary L-methionine restriction decreases oxidative stress in porcine liver mitochondria. | Exp Gerontol | 2015 | https://conductscience.org/library/papers/25765145 | PubMed |
| 17 | 12543260 | Nutritional control of aging. | Exp Gerontol | 2003 | https://conductscience.org/library/papers/12543260 | PubMed |
| 18 | 4524624 | The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4524624 | PubMed |
| 19 | 1905913 | Anti-tumor effect of L-methionine-deprived total parenteral nutrition with 5-fluorouracil administration on Yoshida sarcoma-bearing rats. | Ann Surg | 1991 | https://conductscience.org/library/papers/1905913 | PubMed |
| 20 | 16897757 | Selective amino acid restriction targets mitochondria to induce apoptosis of androgen-independent prostate cancer cells. | J Cell Physiol | 2006 | https://conductscience.org/library/papers/16897757 | PubMed |
Cited by109
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42552759 | Metabolic Dysfunction and Inflammation in Diabetic Retinopathy: Insights From Metabolomics and Cytokine Analysis. | Mediators Inflamm | 2026 | https://conductscience.org/library/papers/42552759 | PubMed |
| 42393218 | Choline-dependent methionine metabolism supports leukemia progression. | Commun Biol | 2026 | https://conductscience.org/library/papers/42393218 | PubMed |
| 42232608 | Microbiome and Response to Therapy in Triple Negative Breast Cancer: A Systematic Review. | Oncol Res | 2026 | https://conductscience.org/library/papers/42232608 | PubMed |
| 42156569 | Methionine concentration regulates LSD1 acetylation in glioma cells. | Amino Acids | 2026 | https://conductscience.org/library/papers/42156569 | PubMed |
| 42151501 | Solute carrier transporters as metabolic gatekeepers in tumor-microenvironment crosstalk. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42151501 | PubMed |
| 42150480 | Identification of metabolism-associated molecular classification and prognostic genes for medulloblastoma based on bioinformatics analysis. | Clinics (Sao Paulo) | 2026 | https://conductscience.org/library/papers/42150480 | PubMed |
| 42082777 | Structures of the neutral amino acid transporter LAT4 provide insights into antitumor effects of its inhibitor tubeimoside-1. | EMBO J | 2026 | https://conductscience.org/library/papers/42082777 | PubMed |
| 41889639 | Identification of disease ameliorated metabolite candidates from Gut Microbes and their interacting targets based on a novel estimating function. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41889639 | PubMed |
| 41659612 | Methionine metabolism and the NOP2 methyltransferase are essential for MYC-Driven liver tumorigenesis. | bioRxiv | 2026 | https://conductscience.org/library/papers/41659612 | PubMed |
| 41559043 | Intermittent fasting inhibits Tp53-driven glioma through gut microbiota-mediated methionine-m6A regulation. | Nat Commun | 2026 | https://conductscience.org/library/papers/41559043 | PubMed |
| 41550357 | Methionine restriction for cancer therapy: From preclinical studies to clinical trials. | Cancer Pathog Ther | 2026 | https://conductscience.org/library/papers/41550357 | PubMed |
| 41516200 | The Double-Edged Nature of Methyl Donors in Cancer Development from Prevention to Progression. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516200 | PubMed |
| 41445748 | Emerging roles for methionine metabolism in immune cell fate and function. | Front Immunol | 2025 | https://conductscience.org/library/papers/41445748 | PubMed |
| 41415289 | "Dissecting the role of T cell exhaustion in cancer progression: a multifaceted approach". | Front Immunol | 2025 | https://conductscience.org/library/papers/41415289 | PubMed |
| 41377684 | Cysteine Restriction Induces Ferroptosis Depending on the S-adenosylmethionine and Polyamine Biosynthetic Pathways in Hepatic Cancer Cells. | Gastro Hep Adv | 2026 | https://conductscience.org/library/papers/41377684 | PubMed |
| 41078537 | Metabolomics in cancer detection: A review of techniques, biomarkers, and clinical utility. | Biomedicine (Taipei) | 2025 | https://conductscience.org/library/papers/41078537 | PubMed |
| 41008516 | Carboxy-Methylation of the Catalytic Subunit of Protein Phosphatase 2A (PP2Ac) Integrates Methionine Availability with Methionine Addicted Cancer Cell Proliferation. | Biomolecules | 2025 | https://conductscience.org/library/papers/41008516 | PubMed |
| 40720007 | Multi-omics analysis revealed the addiction to glutamine and susceptibility to de novo lipogenesis of endometrial neoplasm. | Sci China Life Sci | 2025 | https://conductscience.org/library/papers/40720007 | PubMed |
| 40687236 | Integrated single-cell and bulk RNA sequencing reveals prognostic and immunotherapy-associated myofibroblastic cancer-associated fibroblast subtypes in head and neck squamous cell carcinoma. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40687236 | PubMed |
| 40685729 | Polyamines in Cancer: Mechanisms, Metabolic Targets, and Therapeutic Opportunities. | Anticancer Agents Med Chem | 2026 | https://conductscience.org/library/papers/40685729 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32138282
GET https://conductscience.org/api/papers/v1/32138282/references?page=2